Kerala Ayurveda
214.90
+25.60(+13.52%)
Market Cap₹279.27 Cr
PE Ratio-10.12
IndustryHealthcare
Company Performance:
1D+13.52%
1M-0.58%
6M-53.50%
1Y-40.70%
5Y+302.81%
View Company Insightsright
More news about Kerala Ayurveda
19Feb 26
Kerala Ayurveda Limited Schedules Extraordinary General Meeting for March 14, 2026 to Consider Preferential Equity Share Issuance
Kerala Ayurveda Limited has scheduled an extraordinary general meeting for March 14, 2026, to consider preferential equity share issuances totaling Rs. 30.66 crore. The proposals include issuing 6,30,000 shares to promoter group entity Katra Holding Private Limited for Rs. 20,66,33,700 to convert existing loans, and 3,04,887 shares worth Rs. 9,99,99,887.13 for acquiring additional 26% stake in subsidiary Ayurvedagram Heritage Wellness Centre Private Limited. The meeting will also address amendments to the company's ESOP 2023 plan.
 no imag found
12Feb 26
Kerala Ayurveda Board Approves Q3FY26 Results, ₹30.66 Crore Preferential Issue & Subsidiary Acquisition
Kerala Ayurveda Limited's board meeting on February 12, 2026 resulted in approval of Q3FY26 financial results, a significant ₹30.66 crore preferential equity issue comprising loan conversion and subsidiary acquisition payments, and strategic moves to make Ayurvedagram a wholly owned subsidiary, with EGM scheduled for March 14, 2026.
 no imag found
04Feb 26
Kerala Ayurveda Receives Settlement Order from SEBI
Kerala Ayurveda has received a settlement order from SEBI, concluding regulatory proceedings with India's capital markets regulator. The settlement order represents a formal resolution mechanism that allows companies to resolve regulatory matters without full adjudication proceedings.
 no imag found
20Jan 26
Kerala Ayurveda Limited Successfully Passes Three Special Resolutions Through Postal Ballot E-Voting
Kerala Ayurveda Limited successfully completed its postal ballot process on January 19, 2026, with all three special resolutions receiving overwhelming shareholder approval exceeding 99.99%. The resolutions covered asset charge creation, investment approvals, and director re-appointment, with 4,220,164 votes representing 34.99% of outstanding shares participating in the e-voting process.
 no imag found
27Dec 25
Kerala Ayurveda Forms JV in Bali for Wellness Services
Kerala Ayurveda Limited's subsidiary Nutraveda PTE LTD has formed a 50-50 joint venture with Monica Mohindra to establish Pt. Kerala Ayurveda Bali in Indonesia. The new entity will focus on sports education, wellness, and hospitality services. The joint venture has an authorized share capital of IDR 10 billion and a paid-up capital of IDR 2.5 billion. The agreement includes provisions for share transfers and governance mechanisms to protect both parties' interests.
 no imag found
19Dec 25
Kerala Ayurveda Dispatches Postal Ballot Notice for Shareholder Approvals
Kerala Ayurveda Limited officially dispatched its postal ballot notice on December 19, 2025, seeking shareholder approval through remote e-voting on three critical matters: creation of asset charges up to ₹250 crores, financial operations authorization up to ₹100 crores, and re-appointment of Ms. Shilpa Kiran Gududur as Independent Director for a second five-year term from February 2026 to February 2031.
 no imag found
18Dec 25
Kerala Ayurveda Sets Up European Subsidiary
Kerala Ayurveda Ltd has formed a new wholly owned subsidiary, Kerala Ayurveda Europe B.V., to expand its operations in the European market. This strategic move aims to enhance the company's international presence, improve regulatory compliance, and better serve European customers. The subsidiary will enable Kerala Ayurveda to operate more effectively within the European regulatory framework and capitalize on the growing interest in ayurvedic products in the region.
 no imag found
18Dec 25
Kerala Ayurveda Registers European Subsidiary for Ayurvedic Wellness Expansion
Kerala Ayurveda Limited has established a step-down wholly owned subsidiary, Kerala Ayurveda Europe B.V., through its existing subsidiary Nutraveda PTE LTD. The new entity will focus on importing, marketing, and distributing certified Ayurveda products and operating Ayurveda clinics in Europe. Nutraveda PTE LTD has subscribed to 120 equity shares of ₹0.01 each, totaling an investment of ₹1.20. The subsidiary formation is not considered a Related Party Transaction, and the promoter group has no interest in the new entity.
 no imag found
10Dec 25
Kerala Ayurveda Grants 1,54,752 Stock Options to Employees Under ESOP 2023
Kerala Ayurveda Limited granted 1,54,752 stock options to eligible employees under ESOP 2023 at ₹10 per option on December 10, 2025. The options will vest over 4 years with different schedules for employee categories, and once exercised, will convert to equity shares of ₹10 face value each.
 no imag found
15Nov 25
Kerala Ayurveda Reports Strong H1 Growth, Unveils Vision 2030
Kerala Ayurveda Limited (KAL) reported a 27% revenue growth in H1, reaching Rs. 74.62 crores. The company maintained a positive adjusted EBITDA of Rs. 4.40 crores. KAL's India E-commerce segment grew by 50%, while US Wellness Centres saw 82% growth. The company announced its Vision 2030 plan, targeting Rs. 1000 crores revenue by 2030, with 20x growth in Global E-Product Business and 10x growth in Health Services Business. KAL also expanded its global presence with a new clinic in Singapore.
 no imag found
14Nov 25
Kerala Ayurveda Reports Q2 FY2025 Results: Consolidated Loss Widens Amid Revenue Growth
Kerala Ayurveda's Q2 FY2025 results show consolidated revenue growth of 21.76% to Rs. 3,483.85 lakhs. However, the company faced profitability challenges with a standalone net loss of Rs. 540.06 lakhs and a consolidated net loss of Rs. 635.94 lakhs, compared to a profit in Q1. Total assets stood at Rs. 13,545.80 lakhs with Rs. 490.98 lakhs in cash and cash equivalents. The Board approved these unaudited results on November 14, 2025.
 no imag found
04Sept 25
Kerala Ayurveda Promoter Katra Phytochem Offloads Substantial Stake in Open Market
Katra Phytochem (India) Private Limited, a promoter of Kerala Ayurveda Limited, has sold 324,000 equity shares in the open market on September 2 and 3, 2025. This reduced Katra Phytochem's shareholding from 324,399 shares (2.69% of total voting capital) to just 399 shares (0.00%). The sale was disclosed to the Bombay Stock Exchange on September 4, 2025, in compliance with SEBI regulations. Kerala Ayurveda's total equity share capital remains unchanged at 12,060,198 shares.
 no imag found
05Aug 25
Kerala Ayurveda: Promoter Katra Phytochem Reduces Stake to 2.70% in Open Market Sale
Katra Phytochem (India) Private Limited, a promoter of Kerala Ayurveda Limited (KAL), sold 200,000 equity shares in the open market on August 04, 2025. This transaction reduced Katra Phytochem's shareholding from 4.36% to 2.70% of KAL's total share capital. The sale was reported in compliance with SEBI regulations. KAL's total equity share capital remains unchanged at 120,32,451 shares.
 no imag found
23Jun 25
Kerala Ayurveda Shares Soar 20% Amid Major Block Deals
Kerala Ayurveda Ltd. experienced a 20% stock price increase following block deals involving about 22 lakh shares (18.3% of total equity). Market sources suggest promoters as potential sellers and HNIs as buyers. The stock was trading at ₹488.00, up 13.7%, reversing its previous downtrend.
 no imag found
Kerala Ayurveda
214.90
+25.60
(+13.52%)
1 Year Returns:-40.70%
Industry Peers
Sun Pharmaceutical
1,694.60
(+0.06%)
Divis Laboratories
5,821.00
(-0.61%)
Torrent Pharmaceuticals
4,011.60
(+0.61%)
Lupin
2,279.90
(+0.24%)
Dr Reddys Laboratories
1,217.80
(+0.04%)
Cipla
1,200.90
(+0.71%)
Zydus Life Science
866.30
(+0.24%)
Mankind Pharma
2,017.70
(+0.96%)
Aurobindo Pharma
1,340.40
(+0.50%)
Alkem Laboratories
5,236.50
(-0.41%)